The kinase pathway comprising RAS, RAF, mitogen-activated protein kinase kinase (MEK)
and extracellular signal regulated kinase (ERK) is activated in most human tumours, often …

ContextThe incidence of cutaneous melanoma has increased over the past several decades,
making its early diagnosis a continuing public health priority. The ABCD (Asymmetry, …

The highly aggressive character of melanoma makes it an excellent model for probing the
mechanisms underlying metastasis, which remains one of the most difficult challenges in …

The immunoregulatory protein T-cell immunoglobulin- and mucin-domain–containing
molecule-3 (Tim-3) mediates T-cell exhaustion and contributes to the suppression of immune …

Transcriptional heterogeneity among malignant cells of a tumor has been studied in individual
cancer types and shown to be organized into cancer cell states; however, it remains …

Resistance to RAF- and MEK-targeted therapy is a major clinical challenge 1 , 2 , 3 , 4 . RAF
and MEK inhibitors are initially but only transiently effective in some but not all patients with …

Cancer is a disease consisting of both genetic and epigenetic changes. Although increasing
evidence demonstrates that tumour progression entails chromatin-mediated changes such …

To metastasize, a tumor cell must acquire abilities such as the capacity to colonize new tissue
and evade immune surveillance. Recent evidence suggests that microRNAs can promote …

Malignant melanoma is fatal in its metastatic stage. It is therefore essential to unravel the
molecular mechanisms that govern disease progression to metastasis. MicroRNAs (miRs) are …

Purpose: We have shown that the aged microenvironment increases melanoma metastasis,
and decreases response to targeted therapy, and here we queried response to anti-PD1. …